
News|Articles|September 2, 2004
- Pharmaceutical Technology-09-02-2004
- Volume 28
- Issue 9
Promoting Quality in Drug Manufacturing
Author(s)Jill Wechsler
FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.
Advertisement
Articles in this issue
almost 22 years ago
In the Spotlight-September 2004almost 22 years ago
Automation in a Digital, Webbed, and Wireless Agealmost 22 years ago
September 2004almost 22 years ago
Design of an Aseptic Process Simulationalmost 22 years ago
Early Development Still Driving CRO Performancealmost 22 years ago
Particulate-Free PalletsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology
4
The FDA Moves to Modernize Drug Manufacturing Registration
5




